StockData
CABRNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31

Caring Brands, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.20−0.02 (-1.64%)

Close on Oct 19, 2026

Market cap
$10.79M
P/E (TTM)
–
Dividend yield
–

About Caring Brands

Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844

Caring Brands, Inc. is a wellness consumer products company that develops over-the-counter and cosmetic formulations targeting specialized health and personal care needs. The company's product pipeline features treatments for skin conditions such as vitiligo and eczema, solutions for hair loss, protective suncare formulations, and women's sexual wellness offerings. Key products include Photocil, a topical narrow-band ultraviolet phototherapy product for vitiligo and psoriasis, and JW-700, a topical enzyme booster formulated to enhance the efficacy of minoxidil. Caring Brands serves retail consumers directly as well as through commercial licensing partners.

The company operates in international markets including India, where products are distributed through a licensing agreement with Cosmofix and San Pellegrino Cosmetics, while pursuing distribution across the United States, Asia, and other regions. Contract manufacturing is conducted in Haryana, India. Caring Brands, Inc. maintains its principal executive offices in Fort Pierce, Florida.

Summary of the business section of Caring Brands's latest annual report, written by StockData.

Company profile

Company

Legal name
Caring Brands, Inc.
Headquarters
Fort Pierce, FL
Address
130 S Indian River Drive, Suite 202 Pbm# 1232 34950
Phone
(561) 896-7616
Industry
Perfumes, Cosmetics & Other Toilet Preparations
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
M&K CPAS, PLLC, The Woodlands, Texas

Stock & identifiers

Ticker
CABR
Exchange
Nasdaq
IPO date
Nov 14, 2025
Shares outstanding
10M, Aug 13, 2026
Public float
$3.96M, Jun 30, 2025
Filer category
<br>Emerging growth company
SEC CIK
2020737
CUSIP
14216J109
ISIN
US14216J1097
EIN
99-4103908

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Brian JohnInterim CFO, Director600,000
Glynn WilsonChief Executive Officer, Director672,592
Brian MeadowsChief Financial Officer–
Tyler Thomas MooreChief Financial Officer300,000
Hector W. AlilaDirector50,000
Christopher MeltonDirector–
Christopher Matthew GaletaDirector–

Corporate history

Events identified from SEC filings